Cardiologist William O’Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit, is organizing COVID-19 clinical trials in Detroit with cardiologists at four hospitals. With cardiac trial enrollments at a standstill, Henry Ford's cardiology department offered its research capabilities in the fight against COVID-19.
The collaboration initiated its first 3,000 patient trials April 9 to test if hydroxychloroquine help prevent the onset of COVID-19 in front-line clinicians, first responders and other essential workers. can to bring large-scale novel coronavirus (COVID-19, SARS-CoV-2) drug trials to southeast Michigan.
Four metropolitan Detroit hospital systems and a leading research university, Henry Ford Health System, Ascension, Detroit Medical Center (DMC), Beaumont and Wayne State University, are collaborating to bring large-scale COVID-19 drug trials to southeast Michigan.
The current WHIP COVID-19 Trial will include three arms in this randomized, blinded trial testing safety and efficacy of hydroxychloroquine in first-responder and front-line healthcare workers. They will be divided into a low-dose arm, high-dose arm and a placebo arm.
Read more about the trials in the article First Large-scale U.S. Study on Hydroxychloroquine COVID-19 Prophylaxis Begins in Detroit
Read more about O'Neill and other cardiologists heading the COVID-19 trial collaboration.
Read the FDA document on the trial
Related COVID-19 Cardiology Content:
VIDEO: Overview of Hydroxychloroquine and FDA Warning in its use to Treat COVID-19 — Interveiew with Marianne Pop, Pharm.D.
FDA Reports of Deaths and Injuries From Use of Antimalarial hydroxychloroquine in COVID-19 Patients
VIDEO: Cardiologists Manage Trial Testing if Hydroxychloroquine Protects Clinicians From COVID-19 — Interview with Bill O'Neill, M.D.
FDA Reports of Deaths and Injuries From Use of Antimalarial Drugs in COVID-19 Patients
New York City Physicians Note Multiple Cardiovascular Presentations of COVID-19
FDA Approves ECMO to Treat COVID-19 Patients
COVID-19 STEMI Registry Created to Study Acute Cardiovascular Effects of the Virus
Image Gallery Showing Impact of the COVID-19 Pandemic
VIDEO: Best Practices for Nuclear Cardiology During the COVID-19 Pandemic
VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak — Interview with Ehtisham Mahmud, M.D.
ACC COVID-19 recommendations for the cardiovascular care team
VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.
The Cardiac Implications of Novel Coronavirus
2555 Views
Recent Videos View all 644 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Sponsored Videos View all 46 items
Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.
Watch the video to check out how TrueVue can help improve views of LAA and MV morphology.
Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*
Watch the video to see how you can put “smart” to work with the latest AI-powered quantification tools.
*External study with external sonographers comparing the results of 18 exams with and without AutoMeasure
The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer.
Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more.
Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.
Conference Coverage View all 460 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cath Lab View all 316 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cardiac Imaging View all 287 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cardiac Diagnostics View all 78 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
EP Lab View all 83 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Information Technology View all 169 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)